Seth Hetherington V.

VP, Clinical Development & CMO, INHIBITEX, INC.

Companies

Genocea (United States)Chief Medical Officer Feb 4, 2014 to Mar 1, 2017¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGenocea (United States), Chief Medical Officer